Zoon's appeal on research

WASHINGTON - Kathryn Zoon, director of the FDA's Center for Biologics Evaluation and Research, has asked the biotechnology industry to support her efforts to prevent the collapse of the center's research programs.

At a presentation to the Biotechnology Industry Organization's board of directors earlier this month, Zoon discussed industry's decision to halt the spending of user fees on activities that are not directly related to product reviews...